IMC 4.82% 8.7¢ immuron limited

Ann: Travelan to progress to Phase 3 Clinical Trials in the US, page-134

  1. 314 Posts.
    lightbulb Created with Sketch. 53
    I think IMC is a take over target.

    Given the low MC, the tight relationship with DoD and travelan sales growing fast,

    With 15milliion in cash, its a no brainer for a bio tech or big pharma to snap it up at this cheap MC and before phase 3. .

    Looking at the buy side, large walls of institutional money.



 
watchlist Created with Sketch. Add IMC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.